HomeERIS • NSE
add
Eris Lifesciences Ltd
Previous close
₹1,631.30
Day range
₹1,610.50 - ₹1,735.90
Year range
₹987.10 - ₹1,910.00
Market cap
233.58B INR
Avg Volume
342.98K
P/E ratio
66.45
Dividend yield
0.43%
Primary exchange
NSE
Market news
Investing.com
19 minutes ago
ATIF Holdings receives Nasdaq notice for minimum bid price non-compliance
0.61%
3.19%
Financials
Income Statement
Revenue
Net income
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 7.03B | 28.38% |
Operating expense | 3.57B | 13.00% |
Net income | 938.40M | 32.24% |
Net profit margin | 13.36 | 3.01% |
Earnings per share | 6.89 | 32.25% |
EBITDA | 2.54B | 83.11% |
Effective tax rate | 20.58% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.28B | -82.98% |
Total assets | 70.33B | -0.22% |
Total liabilities | 37.61B | -1.71% |
Total equity | 32.72B | — |
Shares outstanding | 136.00M | — |
Price to book | 7.77 | — |
Return on assets | — | — |
Return on capital | 7.51% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 938.40M | 32.24% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2007
Website
Employees
3,620
